Commentary on "Two-Year Outcomes of Prostatic Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: An International, Multicenter, Prospective Study"

Affiliations

¹ Department of Radiology, Stanford University, Stanford, USA.
² Division of Interventional Radiology, Department of Radiology, 300 Pasteur Drive, Stanford, CA, 94305, USA. apicel@stanford.edu.

Editorial

Katherine L McNamara et al. Cardiovasc Intervent Radiol. 2024 Nov.

. 2024 Nov;47(11):1525-1526.

doi: 10.1007/s00270-024-03885-9. Epub 2024 Oct 26.

¹ Department of Radiology, Stanford University, Stanford, USA.
² Division of Interventional Radiology, Department of Radiology, 300 Pasteur Drive, Stanford, CA, 94305, USA. apicel@stanford.edu.

No abstract available

References

1. Sapoval MR, Bhatia S, Déan C, Rampoldi A, Carnevale FC, Bent C, Tapping CR, Bongiovanni S, Taylor J, Brower JS, Rush M, McWilliams JP, Little MW. PROstate Study investigators two-year outcomes of prostatic artery embolization for symptomatic benign prostatic hyperplasia an international multicenter prospective study. Cardiovasc Intervent Radiol. 2024. https://doi.org/10.1007/s00270-024-03802-0 . - DOI - PubMed
1. Xu Z, Zhou CG, Tian W, et al. Long-term efficacy and recurrence prediction of prostatic artery embolization for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2022;45(12):1801–9. - DOI - PubMed
1. Bilhim T, Costa NV, Torres D, et al. Long-term outcome of prostatic artery embolization for patients with benign prostatic hyperplasia: single-centre retrospective study in 1072 patients over a 10-year period. Cardiovasc Intervent Radiol. 2022;45(9):1324–36. - DOI - PubMed